Momenta Pharmaceuticals, Inc. announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced total revenue was USD 42.822 million compared to USD 64.608 million a year ago. Operating loss was USD 9.670 million compared to operating Income of USD 12.633 million a year ago. Net loss was USD 8.245 million compared to net income of USD 13.759 million a year ago. Basic loss per share was USD 0.1 compared to basic earnings per share of USD 0.18 a year ago. For the full year, total revenue was USD 75.589 million compared to USD 138.882 million a year ago. Operating loss was USD 181.327 million compared to USD 92.551 million a year ago. Net loss was USD 176.061 million compared to USD 88.096 million a year ago. Basic loss per share was USD 2.26 compared to USD 1.2 a year ago.